| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $-0.0B | $-0.1B | $-0.2B | $0.0B | $0.1B | $0.1B | $-0.2B |
| EPS (Basic) | $3.31 | $-0.51 | $-1.86 | $-2.05 | $0.05 | $1.22 | $1.78 | $-5.07 |
| EPS (Diluted) | $3.30 | $-0.51 | $-1.86 | $-2.05 | $0.05 | $1.21 | $1.78 | $-5.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.0B | $13.5B | $12.3B | $9.4B | $5.3B | $5.5B | $13.3B | $8.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.2B | $0.1B | $0.3B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | $18.7B | $12.2B | $11.1B | $8.3B | $4.1B | $4.6B | $11.8B | $7.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.3B | $1.4B | $1.3B | $1.1B | $1.1B | $0.9B | $1.4B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.3B | $0.1B | $0.1B | $0.0B | $-0.3B | $-0.0B | $0.1B |
| Investing Cash Flow | $-7.3B | $-1.7B | $-3.0B | $-3.9B | $0.5B | $7.1B | $-4.4B | $0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $7.3B | $1.3B | $3.0B | $3.5B | $-0.3B | $-6.9B | $4.5B | $-0.6B |